Cite

HARVARD Citation

    Hinterberger, M. et al. (n.d.). P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies. Journal for immunotherapy of cancer. p. A37. [Online]. 
  
Back to record